For example, both SCLC and NEPC exhibit concurrent genetic loss of tumor suppressors RB1 and TP53, as well as mutually exclusive expression of C‐MYC (MYC), N‐MYC (MYCN) or L‐MYC (MYCL).11 Here, MYC is linked to small cell lung carcinoma.